OTCMKTS:KWBT Kiwa Bio-Tech Products Group (KWBT) Stock Price, News & Analysis $0.0002 0.00 (0.00%) As of 09/25/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Kiwa Bio-Tech Products Group Stock (OTCMKTS:KWBT) Get KWBT alerts:Sign Up Key Stats Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.0001▼$0.0010Volume2,600 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Kiwa Bio-Tech Products Group Co., Ltd. is a China-based company focused on the research, development and commercialization of microbial based solutions for agriculture and environmental protection. Through its integrated approach, Kiwa Bio-Tech designs and manufactures biofertilizers, soil conditioners and biopesticides that leverage naturally occurring microorganisms to enhance crop yields, improve soil health and promote sustainable farming practices. The company’s offerings are tailored to support modern agricultural systems while reducing reliance on chemical inputs. In its product portfolio, Kiwa Bio-Tech provides a range of liquid and granular formulations containing beneficial bacteria and fungi strains selected for their ability to fix nitrogen, solubilize phosphorus and suppress soil-borne pathogens. Beyond agricultural applications, the company develops bioaugmentation and bioremediation solutions aimed at treating industrial wastewater, contaminated soils and other environmental liabilities. These services often involve on-site microbial inoculation and ongoing monitoring to restore ecological balance and minimize polluting discharges. Headquartered in Tianjin, Kiwa Bio-Tech operates production facilities in key agricultural regions of China and maintains a network of technical service centers to support local growers. The company’s international reach extends through export partnerships in Southeast Asia, the Middle East and Latin America, where demand for eco-friendly farming inputs is on the rise. Kiwa Bio-Tech’s management team includes seasoned professionals in microbiology, agronomy and environmental engineering who guide strategic investments in R&D and quality control. By combining scientific expertise with field-based support, Kiwa Bio-Tech aims to foster resilient agricultural ecosystems and sustainable environmental outcomes.AI Generated. May Contain Errors. Read More Receive KWBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kiwa Bio-Tech Products Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KWBT Stock News HeadlinesKiwa Bio-Tech Products Group Corp.February 14, 2025 | thestreet.comWhat Is AI Best at Now? Improving Products You Already OwnSeptember 15, 2024 | wsj.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.July 1 at 1:00 AM | Paradigm Press (Ad)23+ products our editors tried and loved in JulyAugust 2, 2024 | nbcnews.com23+ products our editors tried and loved in JulyAugust 2, 2024 | nbcnews.comFinancial Products Group Co. Ltd.May 8, 2024 | wsj.comBBBT Black Bird Biotech, Inc.April 30, 2024 | seekingalpha.comDupharma Biotech forms R&D partnerships for new therapiesMarch 17, 2024 | markets.businessinsider.comSee More Headlines KWBT Stock Analysis - Frequently Asked Questions How have KWBT shares performed this year? Kiwa Bio-Tech Products Group's stock was trading at $0.0002 at the beginning of 2026. Since then, KWBT shares have increased by 0.0% and is now trading at $0.0002. How were Kiwa Bio-Tech Products Group's earnings last quarter? Kiwa Bio-Tech Products Group Corp. (OTCMKTS:KWBT) released its quarterly earnings results on Tuesday, November, 20th. The company reported $0.04 earnings per share for the quarter. The firm earned $7.73 million during the quarter. How do I buy shares of Kiwa Bio-Tech Products Group? Shares of KWBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Kiwa Bio-Tech Products Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Kiwa Bio-Tech Products Group investors own include FuelCell Energy (FCEL), Aemetis (AMTX), CloudCommerce (CLWD), Vapor (HCMC), Hydrofarm Holdings Group (HYFM), Kopin (KOPN) and Company Calendar Last Earnings11/20/2018Today7/01/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry CHEM - DIVERSIFD Sub-IndustryChemicals Current SymbolOTCMKTS:KWBT CIK1159275 Webwww.kiwabiotech.com Phone(909) 456-8828Fax626-626-7665Employees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:KWBT) was last updated on 7/1/2026 by MarketBeat.com Staff. From Our PartnersTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredElon’s new "tollbooth"The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...Weiss Ratings | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiwa Bio-Tech Products Group Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiwa Bio-Tech Products Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.